Sabby Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Sabby Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,815	Closed	-$114K	–	137
2020 Q1	$114K	Buy	+5,815	New	+$195K	0.05%	62
2019 Q1	–	Sell	-4,783	Closed	-$355K	–	144
2018 Q4	$355K	Sell	4,783 -2,382	-33%	-$302K	0.08%	61
2018 Q3	$12.4M	Sell	7,165 -7,141	-50%	-$1.05M	1.59%	18
2018 Q2	$2.04M	Buy	14,306 +7,627	+114%	+$1.15M	0.32%	44
2018 Q1	$1.18M	Buy	+6,679	New	+$2.23M	0.14%	57
2017 Q1	–	Sell	-148	Closed	-$81K	–	342
2016 Q4	$81K	Hold	148	–	–	﹤0.01%	272
2016 Q3	$82K	Sell	148 -36	-20%	-$28.7K	﹤0.01%	294
2016 Q2	$170K	Hold	184	–	–	0.01%	254
2016 Q1	$296K	Hold	184	–	–	0.01%	240
2015 Q4	$287K	Sell	184 -49	-21%	-$95.5K	0.02%	269
2015 Q3	$647K	Sell	233 -14	-6%	-$78.6K	0.03%	276
2015 Q2	$1.26M	Buy	247 +45	+22%	+$278K	0.05%	207
2015 Q1	$1.43M	Buy	+202	New	+$1.52M	0.06%	167

Other funds holding ZSAN

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Sabby Management's ZSAN Position: Q2 2020 in Review

Sabby Management sold out of Zosano Pharma Corporation (ZSAN) in Q2 2020, closing a stake of 5,815 shares — an estimated $114K sold.

Sabby Management first reported a position in ZSAN in Q1 2015 and held it in 13 quarters. The position peaked at $12.4M in Q3 2018. 31 funds tracked by Wall St. Rank hold ZSAN as of Q2 2020.

Sabby Management reported no remaining Zosano Pharma Corporation position as of Q2 2020 after selling out during the quarter.
Sabby Management sold 5,815 Zosano Pharma Corporation shares in Q2 2020, an estimated $114K.
Sabby Management first reported a position in Zosano Pharma Corporation in Q1 2015 and held it in 13 quarters.
Sabby Management's Zosano Pharma Corporation position peaked at $12.4M in Q3 2018.
31 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2020.

Based on Sabby Management's 13F filing for Q2 2020, filed 14 Aug 2020.